Erik Walldén
Pharmaceuticals
Beactica
Sweden
Biography
Mr Erik Walldén (1949) has a record of achievement from over 30 years leadership in the international Life Science industry. He has led the global launching of several new technologies, established and restructured companies, successfully closed private placements and IPOs. He is currently acting as consultant and advisor through his own company Erik Wallden AB. Erik has been the CEO for the Swedish company Gyros AB (2009–2013). Before that he was the CEO of the Swedish biotech company Affibody Holding AB (2006–2009), Biacore International AB (2004–2006), and before that the CEO of Pyrosequencing AB (1998–2004). Erik has been active in establishing and part of the executive management of companies such as the US based PerSeptive Biosystems Inc., Pharmacia Biosensor AB and Pharmacia Biotech AB. He is the Chairman of the Board of Erik Wallden AB, Directors of Virgin Instruments Inc., and CellSeed AB.
Research Interest
strategic planning, business development, pharmaceutical R&D and quality assurance
